{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:15:02Z","timestamp":1788552902196,"version":"build-2803163510"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1112245"],"award-info":[{"award-number":["OPP1112245"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,31]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The introduction and rollout of a meningococcal serogroup A conjugate vaccine, MenAfriVac, in the African meningitis belt has eliminated serogroup A meningococcal infections for &gt;300 million Africans. However, serogroup C, W, and X meningococci continue to circulate and have been responsible for focal epidemics in meningitis belt countries. Affordable multivalent meningococcal conjugate vaccines are being developed to prevent these non-A epidemics. This article describes the current epidemiologic situation and status of vaccine development and highlights questions to be addressed to most efficiently use these new vaccines.<\/jats:p>","DOI":"10.1093\/infdis\/jiz297","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T19:08:43Z","timestamp":1562353723000},"page":"S274-S278","source":"Crossref","is-referenced-by-count":27,"title":["Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines"],"prefix":"10.1093","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0697-6149","authenticated-orcid":false,"given":"Mark R","family":"Alderson","sequence":"first","affiliation":[{"name":"Center for Vaccine Innovation and Access, PATH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F Marc","family":"LaForce","sequence":"additional","affiliation":[{"name":"Bill & Melinda Gates Foundation, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajoke","family":"Sobanjo-ter Meulen","sequence":"additional","affiliation":[{"name":"Angela Hwang Consulting, Albany, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Hwang","sequence":"additional","affiliation":[{"name":"Technical Services, Serum Institute of India Pvt Ltd, Pune, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Preziosi","sequence":"additional","affiliation":[{"name":"Immunization, Vaccines, and Biologicals, World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith P","family":"Klugman","sequence":"additional","affiliation":[{"name":"Angela Hwang Consulting, Albany, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,31]]},"reference":[{"key":"2019110101093486900_CIT0001","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0035-9203(99)90106-2","article-title":"Manson lecture. Meningococcal meningitis in Africa","volume":"93","author":"Greenwood","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2019110101093486900_CIT0002","doi-asserted-by":"crossref","first-page":"S410","DOI":"10.1093\/cid\/civ597","article-title":"Meningococcal meningitis surveillance in the African meningitis belt, 2004\u20132013","volume":"61","author":"Lingani","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2019110101093486900_CIT0003","first-page":"57","article-title":"Meningococcal A conjugate vaccine: updated guidance, February 2015","volume":"90","author":"World Health Organization","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"2019110101093486900_CIT0004","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1473-3099(12)70168-8","article-title":"Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data","volume":"12","author":"Novak","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"2019110101093486900_CIT0005","first-page":"145","article-title":"Epidemic meningitis control in countries of the African meningitis belt, 2016","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"2019110101093486900_CIT0006","article-title":"Status of the rollout of the meningococcal serogroup A conjugate vaccine in African meningitis belt countries in 2018","author":"Bwaka","journal-title":"J Infect Dis"},{"key":"2019110101093486900_CIT0007","article-title":"Meningococcal meningitis outbreaks in the African meningitis belt after meningococcal serogroup A conjugate vaccine introduction, 2011\u20132017","author":"Fernandez","journal-title":"J Infect Dis"},{"key":"2019110101093486900_CIT0008","article-title":"Bacterial meningitis epidemiology in 5 countries in the meningitis belt of sub-Saharan Africa, 2015\u20132017","author":"Soeters","journal-title":"J Infect Dis"},{"key":"2019110101093486900_CIT0009","first-page":"179","article-title":"Epidemic meningitis control in countries in the African meningitis belt, 2018","volume":"94","author":"World Health Organization","year":"2019","journal-title":"Weekly Epidemiological Record"},{"key":"2019110101093486900_CIT0010","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/14760584.2018.1547637","article-title":"Meningococcal B vaccine (4CMenB): the journey from research to real world experience","volume":"17","author":"Rappuoli","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"2019110101093486900_CIT0011","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/14760584.2018.1483726","article-title":"From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine","volume":"17","author":"Perez","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"2019110101093486900_CIT0012","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/B978-1-4160-3611-1.50023-4","article-title":"Meningococcal infections.","volume-title":"Vaccines","author":"Granoff","year":"2008"},{"key":"2019110101093486900_CIT0013","author":"Gavi the Vaccine Alliance"},{"key":"2019110101093486900_CIT0014","author":"World Health Organization"},{"key":"2019110101093486900_CIT0015","unstructured":"World Health Organization. International Coordination Group on Vaccine Provision for Epidemic Meningitis: report of the annual meeting,Geneva, 18 September 2018. Available at: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/279828\/WHO-WHE-IHM-2019.1-eng.pdf?ua=1. Accessed 11 February 2019."},{"key":"2019110101093486900_CIT0016","author":"World Health Organization"},{"key":"2019110101093486900_CIT0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/20477724.2016.1274068","article-title":"Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa","volume":"111","author":"Mohammed","year":"2017","journal-title":"Pathog Glob Health"},{"key":"2019110101093486900_CIT0018","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1016\/j.vaccine.2011.05.058","article-title":"Costs and impact of meningitis epidemics for the public health system in Burkina Faso","volume":"29","author":"Colombini","year":"2011","journal-title":"Vaccine"},{"key":"2019110101093486900_CIT0019","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1086\/644623","article-title":"Costs for households and community perception of meningitis epidemics in Burkina Faso","volume":"49","author":"Colombini","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2019110101093486900_CIT0020","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.biologicals.2013.12.001","article-title":"Process development and immunogenicity studies on a serogroup \u2018X\u2019 meningococcal polysaccharide conjugate vaccine","volume":"42","author":"Chilukuri","year":"2014","journal-title":"Biologicals"},{"key":"2019110101093486900_CIT0021","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S1473-3099(18)30400-6","article-title":"Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study","volume":"18","author":"Chen","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2019110101093486900_CIT0022","author":"Gavi the Vaccine Alliance"},{"key":"2019110101093486900_CIT0023","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/tmi.13185","article-title":"Narrative review of methods and findings of recent studies on the carriage of meningococci and other Neisseria species in the African meningitis belt","volume":"24","author":"Greenwood","year":"2019","journal-title":"Trop Med Int Health"},{"key":"2019110101093486900_CIT0024","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(13)61612-8","article-title":"Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected, Lancet 2014 Jan 4;383(9911):30","volume":"383","author":"Daugla","year":"2014","journal-title":"Lancet"},{"key":"2019110101093486900_CIT0025","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/cid\/cis892","article-title":"Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity","volume":"56","author":"Kristiansen","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2019110101093486900_CIT0026","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/infdis\/jiv211","article-title":"The diversity of meningococcal carriage across the African meningitis belt and the impact of vaccination with a group a meningococcal conjugate vaccine","volume":"212","author":"MenAfriCar Consortium","year":"2015","journal-title":"J Infect Dis"},{"key":"2019110101093486900_CIT0027","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1080\/21645515.2018.1454570","article-title":"Impact of meningococcal vaccination on carriage and disease transmission: a review of the literature","volume":"14","author":"Balmer","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"2019110101093486900_CIT0028","author":"United Nations General Assembly"},{"key":"2019110101093486900_CIT0029","unstructured":"World Health Organization. 14th Annual Meeting on Surveillance, Preparedness, and Response to Meningitis Outbreaks in Africa and Fourth Annual MenAfriNet partners\u2019 meeting, 12\u201315 September 2017;Ouagadougou, Burkina Faso."}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/220\/Supplement_4\/S274\/30339658\/jiz297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/220\/Supplement_4\/S274\/30339658\/jiz297.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T06:25:31Z","timestamp":1610259931000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/220\/Supplement_4\/S274\/5610778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,31]]},"references-count":29,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2019,10,31]]},"published-print":{"date-parts":[[2019,10,31]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz297","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12,1]]},"published":{"date-parts":[[2019,10,31]]}}}